- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05823064
Respiratory Morbidities and Outcome in Late Preterm in Neonatal ICU
Respiratory Morbidities and Outcome in Late Preterm in Neonatal ICU of Assiut University Children Hospital, One Year Study
Aim of the work:
To assess the respiratory morbidities & outcomes in late preterm infants in the neonatal ICU of Assiut university children's Hospital.
Study Overview
Status
Conditions
Detailed Description
In the world, Preterm birth rates continue to rise. Many reasons account for this increase, such as demographic changes, infertility treatments, increases in maternal age, more multiple gestations, increasing obesity rates, and maternal comorbid conditions.
To evaluate the occurrence and impact of a condition, a precise definition and its related outcomes are necessary. Thus, a general classification for selected gestational age categories has been reported. Preterm birth refers to all deliveries < 37-0/7 weeks; this classification includes very preterm (< 32-0/7 weeks), moderately preterm (32-0/7 to 33-6/7 weeks), and late preterm births (34-0/7 to 36-6/7 weeks). Term births refer to deliveries that occur from 37-0/7 to 42-0/7 weeks, and post-term births refer to any delivery occurring after 42-0/7 weeks.
Neonates born between 34 and 36 weeks of gestation (late preterm or near-term births) comprise 71% of all preterm births in the United States.
Late preterm neonates have significantly higher rates of morbidity and mortality relative to those born at term (37-42 weeks).
In addition to higher risks for serious health complications, the mortality rate for late preterm infants is 3-fold higher than that for term infants (7.7 vs 2.5 per 1000 live births).
Late preterm delivery (71% of all preterm births) increases the incidence of respiratory pathology as respiratory distress syndrome (RDS), Transient tachypnea of the newborn (TTN), pneumonia with chest x-ray verification, persistent apnea and bradycardia, pulmonary hypertension, pneumothorax, meconium aspiration, pulmonary hypoplasia,( respiratory failure ) and the need of ventilator support when compared to term delivery.
Late preterm newborns increase other risks for feeding difficulty, jaundice, hypoglycemia, temperature instability, apnea, and respiratory distress.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Alaa N Sadik
- Phone Number: 01098459103
- Email: alaanady6000@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- late preterm neonates admitted to the Neonatal intensive care unit (NICU) at Assiut University Children's Hospital for one year.
Exclusion Criteria:
patients with congenital heart diseases and multiple congenital anomalies.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To assess the respiratory morbidities
Time Frame: base line
|
To assess the respiratory morbidities in late preterm infants in neonatal ICU of Assiut university children hospital .
|
base line
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nafisa H Refaat, Assiut University
- Principal Investigator: Mohamed A Sayed, Assiut University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Respiratory morbidities
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Morbidities
-
Shang-Lin ChiangRecruitingHeart; Complications | Degeneration Muscle | Multiple MorbiditiesTaiwan
-
ABDULZAHRA HUSSAINKing's College Hospital NHS Trust; Spire, Inc.; Heart of England NHS Trust; The... and other collaboratorsCompletedMorality | Revisions After MGB/OAGB | Morbidities
-
Cook County HealthAgency for Healthcare Research and Quality (AHRQ)CompletedMultiple Co-morbiditiesUnited States
-
Respivant Sciences GmbHRespivant Sciences Inc.CompletedRespiratory Morbidities of Prematurity (RMP)United States
-
Aga Khan UniversityUniversitat Pompeu FabraUnknownPerinatal Mortality | Neonatal Morbidities
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19United States, United Kingdom, Belgium, France, Spain, Germany, Philippines, Brazil, Colombia, South Africa
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina
-
Başakşehir Çam & Sakura City HospitalActive, not recruitingMortality | Coronary Artery Bypass | Anesthesia | Cardiac Risk Factors | Morbidities | Histopathology | Fraility | Coronary Arterial Disease (CAD) | Preoperative Cardiac Surgery PatientsTurkey
-
Andrea BranchNational Institute on Drug Abuse (NIDA)Completed
-
Assistance Publique - Hôpitaux de ParisCompletedRespiratory Diseases | Chronic and Acute Respiratory FailureFrance